MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Effect of finger rhythmic movement training on freezing of gait in Parkinson’s disease patients: A study protocol

    H. Nakano, S. Murata, T. Kodama, H. Nakae, M. Soma (Kyoto-city, Japan)

    Objective: To investigate the effect of finger rhythmic movement (FRM) training on freezing of gait (FOG) in Parkinson's disease (PD) patients. Background: External cues such…
  • 2018 International Congress

    Effects of the Lee Silverman Voice Treatment (LSVT LOUD ®) on Facial Expressivity in Individuals with Parkinson’s Disease (PD) as a function of Emotional Valence

    A. Bono, K. Scorpio, R. Stafford, M. Halfacre, E. Murray, J. Twaite, K. Alterescu, J. Spielman, A. Halpern, L. Ramig, J. Borod (Flushing, NY, USA)

    Objective: To examine the effect of LSVT LOUD (Ramig et al., 2011) on facial expressivity in PD as a function of emotional valence. Background: Research…
  • 2018 International Congress

    The anti-dyskinetic effect of the clinically-available 5-HT3 receptor antagonist granisetron in the 6-OHDA-lesioned rat model of Parkinson’s disease

    C. Kwan, I. Frouni, D. Bedard, A. Hamadjida, P. Huot (Montreal, QC, Canada)

    Objective: To determine the effect of the serotonin 3 (5-HT3) receptor antagonist granisetron, a clinically-available anti-emetic, on L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia. Background: Dopamine replacement with L-DOPA…
  • 2018 International Congress

    Relationship between Patient Global Impression of Change and other Efficacy Endpoints in Parkinson’s Disease: A post-hoc analysis from combined BIPARK-I and II

    J. Ferreira, W. Poewe, O. Rascol, R. Costa, E. Arbe, J-F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

    Objective: To evaluate the association of patients’ perception of Parkinson’s Disease (PD) symptoms improvement (as assessed by Patient Global Impression of Change, PGIC) could be…
  • 2018 International Congress

    The combined effect of repetitive transcranial magnetic stimulation and treadmill training in people with Parkinson’s disease – A randomized controlled trial

    C. Chung, M. Mak, M. AuYeung, Y. Chan, N. Cheung, V. Mok, M. Hallett (Hong Kong, Hong Kong)

    Objective: To evaluate the combined effect of repetitive transcranial magnetic stimulation (rTMS) on treadmill training in people with Parkinson’s disease (PD). Background: Previous studies showed…
  • « Previous Page
  • 1
  • …
  • 175
  • 176
  • 177

Most Viewed Abstracts

  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25111 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley